Inhibition of Oestradiol-induced Prolactin Release in a Dual-Cannulated Ovariectomized Rat Model by Carmoxirole, a Peripherally Restricted Dopamine Agonist-Reference-Cited by-同舟云学术

Inhibition of Oestradiol-induced Prolactin Release in a Dual-Cannulated Ovariectomized Rat Model by Carmoxirole, a Peripherally Restricted Dopamine Agonist

Published:2012-07-31 Issue:6 Volume:111 Page:411-416
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharmacol Toxicol

Author:

Brott David A.¹,Werkheiser Jennifer L.¹,Campbell Pam¹,Bentley Patricia¹,Andersson Håkan H. A. S.²,Stewart Jane³,Huby Russell³,Altekar Maneesha⁴,Kinter Lewis B.¹

Affiliation:

1. Global Safety Assessment; AstraZeneca Pharmaceuticals; R&D; Wilmington DE USA

2. Global Safety Assessment; AstraZeneca Pharmaceuticals; R&D; Södertälje Sweden

3. Global Safety Assessment; AstraZeneca Pharmaceuticals; R&D; Alderley Park UK

4. Global Operations; AstraZeneca Pharmaceuticals; R&D; Wilmington DE USA

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Reference35 articles.

1. Preclinical risk assessment of drug-induced hypo- and hyperprolactinemia;Hargreaves;J Appl Toxicol,2011

2. Effects of bromocriptine treatment on immune responses and 3-methylcholanthrene-induced tumorigenesis in rats;Bussiere;Immunopharmacol Immunotoxicol,1991